Colorectal Cancer Clinical Trial

- The folks at Hoffmann-La Roche are studying Colorectal Cancer in individuals ages 18 years and older. This clinical trial is slated to start April 2013 and is expected to end circa August 2016.

888-662-6728 (U.S. Only)
Reference Study ID Number: ML28411
Overall Study Contact Info
StatusName Contact Phone
RecruitingReference Study ID Number: ML28411 (U.S. Only)

This study is officially titled, "Non-interventional Local Study to Describe the Safety, Tolerability and Efficacy of Bevacizumab in Combination With Standard Chemotherapy Regimens as First Line in Patients With Metastatic Cancer of the Colon or the Rectum."


Podgorica, Montenegro - Recruiting

For more study details, please visit this link to record, which is the source of this webpage.